Dopamine-receptor-agonists, therapeutic useNewron-PharmaceuticalsParkinson's-disease, treatmentResearch-and-developmentSafinamide, therapeutic useTrial-result-clinical
according to the press release. They then tested the model in astudypartially funded by the MJFF, a nonprofit that focuses on improving treatment therapies and finding a cure for PD. In the study, the researchers showed that the AI performed...
"It's a tough diagnosis to have to hear because there's a lot of stigma associated with this disease," Jaffe said. However, a new kind of treatment is showing a reduction in symptoms for Parkinson’s patients. Jay Alberts, a neuroscientist and Cleveland Clinic researcher, has conduct...
Apomorphine, adverse reactionsApomorphine, pharmacokineticsApomorphine, therapeutic useDrug-delivery-systemsParkinson's-disease, treatmentTrial-result-clinicalVarious-toxicities, drug-inducedVectura
Despite astounding progress in the biochemical management of Parkinson's disease in particular and of other movement disorders, there are still patients disabled by severe tremor and not by bradykinesia in whom thalamotomy remains the treatment of choice. Though the irreducible complications of surgery...
IMPORTANCE OF THE FIELD: Levodopa (LD) is an efficient drug for patients with Parkinson's disease (PD). Its short half-life supports peaks and troughs. These plasma fluctuations support alternating stimulation of striatal postsynaptic dopamine receptors and thus onset of motor complications. They ...
Roseanne Dobkin and her colleagues (e.g., Dobkin, Interian, Durland, Gara, & Menza, 2018) have developed a 10-session, individual cognitive-behavioral treatment (CBT) program for treating depression in individuals with Parkinson's disease (dPD). The program has been found to yield ...
MAIN RESULTS: Three randomised controlled trials were found comparing amantadine with placebo in the treatment of dyskinesia in patients with idiopathic Parkinson's disease. Three trials were excluded on the basis that they had no control group and a further three did not state whether they ...
Antiparkinsonian-induced-psychotic-disorders, treaAntiparkinsonians, adverse reactionsMovement-disorders, drug-inducedResearch-and-developmentTrial-result-clinicalthe selective 5-ht2a receptor inverse agonist acp 103 may be beneficial for parkinson's disease patients with treatment-induced psychosis...
Levetiracetam, therapeutic useLevodopa, therapeutic useParkinson's-disease, treatment